Sterling Cancer & Diabetic Institute & Research Center Private Limited - Company Profile

It is a healthcare private limited company based in Kalyan, Maharashtra, India, established in 2012.
2012 Kalyan, Maharashtra, India Struck Off
Last Updated:
Access Report
About Sterling Cancer & Diabetic Institute & Research Center Private Limited

Sterling Cancer & Diabetic Institute & Research Center Private Limited, a struck off private limited company, was established on 10 October 2012 in Kalyan, Maharashtra, India. Engaging in hospitals within the healthcare sector, it holds CIN: U85100MH2012PTC236663. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.10 M.

Its leadership includes Abrar Haroon Khan (Director), Umesh Devanand Warghat (Additional Director), Nagesh Bhuneshwar Mourya (Director). Past directors included Ajay Singh, Babu Kamal Satairam Saroj. It holds no open charges and ₹9.50 M settled loans. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at 1/Kalpraj Co-Operative Society Ltd., Bailbazar, Kalyan (West),, Kalyan, Maharashtra, 421301.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100MH2012PTC236663

  • Registration Number

    236663

  • Incorporation Date

    10 October 2012

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 5 Months
  • Last Filing with ROC 31 Mar 2013
  • Satisfied Charges ₹ 9.50 M
Company report

Sterling Cancer & Diabetic Institute & Research Center Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sterling Cancer & Diabetic Institute & Research Center Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sterling Cancer & Diabetic Institute & Research Center Private Limited?
Current Directors
Name Designation Appointment Date Status
Abrar Haroon Khan Director 10 Oct 2012 Current
Umesh Devanand Warghat Additional Director 17 Aug 2013 Current
Nagesh Bhuneshwar Mourya Director 10 Oct 2012 Current
Lalita Yoganand Patil Additional Director 17 Aug 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Jan 2013 Past
Pramod Abcsdd Additional Director 22 Jun 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sterling Cancer & Diabetic Institute & Research Center.

Enhance accessibility to Sterling Cancer & Diabetic Institute & Research Center's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sterling Cancer & Diabetic Institute & Research Center revenue growth over time
Sterling Cancer & Diabetic Institute & Research Center profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sterling Cancer & Diabetic Institute & Research Center?

Unlock access to Sterling Cancer & Diabetic Institute & Research Center's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹9,500,000.00

Charges Breakdown by Lending Institutions
  • Punjab National Bank : 0.95 Cr
Latest Charge Details
Date Lender Amount Status
27 Feb 2013 Punjab National Bank ₹9.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sterling Cancer & Diabetic Institute & Research Center?

Unlock and access historical data on people associated with Sterling Cancer & Diabetic Institute & Research Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sterling Cancer & Diabetic Institute & Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sterling Cancer & Diabetic Institute & Research Center's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sterling Cancer & Diabetic Institute & Research Center
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 27 Feb 2013 via Charge ID 10411626 with Punjab National Bank was fully satisfied on 20 Mar 2017. was completed.

  • Annual General Meeting

    Sterling Cancer & Diabetic Institute & Research Center Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    The activity Umesh Devanand Warghat was appointed as a Additional Director was appointed as a Additional Director on 17 Aug 2013 & has been associated with this company since 12 years 7 months . was completed.

  • Director Appointment

    Progress on Lalita Yoganand Patil was appointed as a Additional Director was appointed as a Additional Director on 17 Aug 2013 & has been associated with this company since 12 years 7 months . was documented.

  • Balance Sheet

    The activity Sterling Cancer & Diabetic Institute & Research Center Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Mumbai. was completed.

  • Charges

    Progress on A charge with Punjab National Bank amounted to Rs. 0.95 Cr with Charge ID 10411626 was registered on 27 Feb 2013. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sterling Cancer & Diabetic Institute & Research Center Private Limited?

The CIN of Sterling Cancer & Diabetic Institute & Research Center Private Limited is U85100MH2012PTC236663.

Where is Sterling Cancer & Diabetic Institute & Research Center Private Limited headquartered?

Sterling Cancer & Diabetic Institute & Research Center Private Limited is headquartered at 1/Kalpraj Co-Operative Society Ltd., Bailbazar, Kalyan (West),, Kalyan, Maharashtra, 421301.

When was Sterling Cancer & Diabetic Institute & Research Center Private Limited incorporated?

Sterling Cancer & Diabetic Institute & Research Center Private Limited was incorporated on 10 October 2012.

Who are the current directors of Sterling Cancer & Diabetic Institute & Research Center Private Limited?

The current directors of Sterling Cancer & Diabetic Institute & Research Center Private Limited are

What is the primary industry of Sterling Cancer & Diabetic Institute & Research Center Private Limited?

The primary industry of Sterling Cancer & Diabetic Institute & Research Center Private Limited is Healthcare.

Is Sterling Cancer & Diabetic Institute & Research Center Private Limited a listed company?

Sterling Cancer & Diabetic Institute & Research Center Private Limited is unlisted.

What is the capital structure of Sterling Cancer & Diabetic Institute & Research Center Private Limited?

The authorized capital of Sterling Cancer & Diabetic Institute & Research Center Private Limited is ₹1.00 Cr, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available